Unapproved device buys time for new pair of lungs

Colder weather brings residential health hazards

Dentist gives back through gift of dental care

Denison toddler fights life-threatening disease

Cell phones believed to cause serious sleep problems

Local vet responds to viral "No Ice Water For Dogs" blog post

Warning signs and how to prevent a drowning

FDA prepping long-awaited plan to reduce salt

Kids get codeine in ER despite risks, guidelines

Load More Stories

CBS News Health Headlines

New guidelines mark the first time the surgery is recommended specifically as treatment for diabetes
New research looks at the different reasons why physicians prescribe the medications
Recent deaths on Mount Everest prompt questions about what happens to the body at high elevations
A new study looks at the consequences of moving bedtimes or letting babies cry it out

WebMD Health News

Incidence up more than 10 percent in 10 years among Americans, study finds

45 professional groups say the procedure improves blood sugar control

Those using the device were nearly 7 percent lighter after six months

Other uses include insomnia, pain and anxiety, researchers say

Two long-recommended methods seem effective and bring no psychological harm, study finds

AP Top Health Stories

Gabor Kovacs of 'smoke no smoke' puffs on an e-cigarette that his shop sells at Camden in LondonBy Kate Kelland LONDON (Reuters) - The number of people in France and Britain who have tried an electronic or e-cigarette has risen sharply in just two years, according to a Europe-wide study published on Tuesday. It found that France had the highest use of e-cigarettes, with the proportion of those who had tried one nearly tripling to 21.3 percent from 7.3 percent. Using data from more than 53,000 people across Europe - with at least 1,000 from each country - the study also found the proportion of people across Europe who consider e-cigarettes dangerous nearly doubled to 51 percent from 27 percent.

In this May 20, 2016, file photo, Vice President Joe Biden listens as President Barack Obama speaks to members of the media in the Oval Office at the White House in Washington Biden will bring together scientists, oncologists, donors and patients for a national conference on cancer research in Washington, the White House said May 24. Dubbed the “National Cancer Moonshot Summit,” the summit is scheduled for June 29 at Howard University, and the White House said it planned to organize dozens regional summits on the same day in communities far from the capital. (AP Photo/Andrew Harnik)WASHINGTON (AP) — Vice President Joe Biden will bring together scientists, oncologists, donors and patients for a national conference on cancer research in Washington, the White House said Tuesday.

Eli Lilly and Co on Tuesday said it and partner Pfizer Inc aim to seek approval by 2018 for a new type of pain drug that could be an alternative to opioids for osteoarthritis, chronic back pain and cancer pain. The Indianapolis drugmaker said tanezumab, given by injection every eight weeks, could be a far more effective and appropriate alternative for chronic pain than opioids, without their abuse potential.

The headquarters of Valeant Pharmaceuticals International Inc. seen in Laval QuebecThe SEC has questioned Valeant's practice of stripping away acquisition-related expenses from its "non-GAAP" or adjusted metrics, given that the drugmaker had been fueling growth through frenzied deal making. In multiple letters, the SEC said Valeant's management is in possession of all the facts and urged for adequate and accurate financial disclosures. "We are concerned with your overall format and presentation of the non-GAAP measures and believe revisions to your future earnings releases and investor materials are appropriate," the SEC said in a letter to the company in February.

SEATTLE (AP) — Washington state and California sued Johnson & Johnson on Tuesday, saying that for years the company misrepresented the risks of vaginal mesh implants it sold to repair pelvic collapse.